Skip to content

Clinical trials

Bile Duct Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bile Duct Neoplasms Clear all

251 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
20017
20025
20034
200410
20058
20066
200710
20089
20098
20106
20115
20124
20138
201410
20157
20169
201712
20188
201910
202018
202110
20229
202312
202413
20257
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed124
Unknown status42
Recruiting30
Terminated27
Active, not recruiting11
Withdrawn8
Not yet recruiting5
Suspended2
No longer available1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)27
Memorial Sloan Kettering Cancer Center7
Mayo Clinic5
Seoul National University Hospital5
Alliance for Clinical Trials in Oncology4
National Institutes of Health Clinical Center (CC)4
Weill Medical College of Cornell University4
Ajou University School of Medicine3
Case Comprehensive Cancer Center3
Chiba University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bile Duct Neoplasms251
Pancreatic Neoplasms115
Gallbladder Neoplasms105
Cholangiocarcinoma72
Stomach Neoplasms69
Carcinoma, Hepatocellular67
Liver Neoplasms52
Colonic Neoplasms50
Esophageal Neoplasms46
Rectal Neoplasms43

Trials

Showing 76 to 100 of 251. Each trial links to its page on Pharma Observatory.

151 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.